Application of narrative nursing combined with risk management in the prognosis of postoperative lung cancer patients

SU Haoran; TIAN Zhongyu; SONG Xuan

doi:10.3969/j.issn.1002-7386.2026.01.036

Abstract：Objective To analyze the application of narrative nursing combined with risk management to the prognosis of postoperative lung cancer patients.Methods A total of 240 postoperative lung cancer patients admitted from January 2022 to January 2024 were included in this study.They were randomly divided into two groups using a random number table,with 120 cases per group.Patients in the control group received routine nursing care,while those in the study group received narrative nursing combined with risk management.Psychological status scores,hope scale scores,postoperative pain scores,sleep disorder scores,social support level scores,and quality of life scores before and after the intervention were compared between the two groups.Postoperative recovery indicators and complications were also analyzed.Results After the intervention,psychological status(depression and anxiety),postoperative pain,and sleep disorder scores significantly decreased compared to pre-intervention values,which were significantly lower in the study group than the control group(P<0.05).Hope levels,social support levels,and quality of life scores significantly increased after the intervention in both groups,which were significantly higher in the study group than the control group(P<0.05).The duration of postoperative spontaneous sputum discharge,significant reduction in pain,and length of hospital stay were significantly shorter in the study group than the control group(P<0.05).The complication rate in the study group was significantly lower than the control group(P<0.05).Conclusion Narrative nursing combined with risk management is superior in improving the psychological status,reducing pain and sleep disturbances,and enhancing social support levels and quality of life.This can be an important component in the comprehensive nursing care of postoperative lung cancer patients that deserves clinical application.